SARS: Epidemiology, clinical presentation, management, and infection control measures

Mayo Clinic Proceedings

Volumn 78, Issue 7, 2003, Pages 882-890

  Sampathkumar, Priya ^a   Temesgen, Zelalem ^a   Smith, Thomas F ^a   Thompson, Rodney L ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CORTICOSTEROID; MACROLIDE; METHYLPREDNISOLONE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIBAVIRIN;

AIRBORNE INFECTION; ANTIBIOTIC THERAPY; CHINA; CLINICAL FEATURE; CORONAVIRUS; CORTICOSTEROID THERAPY; DIAGNOSTIC PROCEDURE; ELECTROLYTE DISTURBANCE; EPIDEMIC; EXPOSURE; FEVER; HEMOLYTIC ANEMIA; HOSPITAL CARE; HUMAN; HYPOKALEMIA; HYPOMAGNESEMIA; INFECTION CONTROL; MORBIDITY; MORTALITY; OUTPATIENT CARE; RESPIRATORY TRACT DISEASE; SARS CORONAVIRUS; SCREENING; SEVERE ACUTE RESPIRATORY SYNDROME; SHORT SURVEY; SIDE EFFECT; VIRUS TRANSMISSION;

EID: 0038170225     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/78.7.882     Document Type: Short Survey

References (20)

1. World Health Organization. Cumulative number of reported probable cases of severe acute respiratory syndrome (SARS). Available at: www.who.int/csr/sarscountry/2003_04_23/en. Accessibility verified June 3, 2003.
2. Centers for Disease Control and Prevention. Preliminary clinical description of severe acute respiratory syndrome. MMWR Morb Mortal Wkly Rep. 2003;52:255-256.
3. Centers for Disease Control and Prevention. Updated interim U.S. case definition of severe acute respiratory syndrome (SARS). Available at: www.cdc.gov/ncidod/sars/casedefinition.htm. Accessibility verified June 5, 2003.
4. Centers for Disease Control and Prevention. Updated interim surveillance case definition for severe acute respiratory syndrome (SARS) - United States, April 29, 2003. MMWR Morb Mortal Wkly Rep. 2003;52:391-393.
5. Poutanen SM, Low DE, Henry B, et al. Identification of severe acute respiratory syndrome in Canada. N Engl J Med. 2003;348:1995-2005.
6. Hsu L-Y, Lee C-C, Green JA, et al. Severe Acute Respiratory Syndrome (SARS) in Singapore: clinical features of index patient and initial contacts. Emerg Infect Dis [serial online]. June 2003. Available at: www.cdc.gov/ncidod/EID/vol9no6/03-0264.htm. Accessibility verified June 4, 2003.
7. Booth CM, Matukas LM, Tomlinson GA, et al. Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area. JAMA. 2003;289:2801-2809. Available at: http://jama.ama-assn.org/cgi/search?fulltext=greater+toronto+area. Accessibility verified June 4, 2003.
8. Peiris JSM, Chu CM, Cheng VCC, et al. HKU/UCH SARS Study Group. Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study. Lancet [serial online]. May 2003. Available at: http://image .thelancet.com/extras/03art4432web.pdf. Accessibility verified June 5, 2003.
9. Hon KLE, Leung CW, Cheng WTF, et al. Clinical presentations and outcome of severe acute respiratory syndrome in children. Lancet [serial online]. April 2003. Available at: http://image.thelancet.com/extras/03let4127web.pdf. Accessibility verified June 4, 2003.
10. Lee N, Hui D, Wu A, et al. A major outbreak of severe acute respiratory syndrome in Hong Kong. N Engl J Med. 2003;348:1986-1994.
11. Peiris JSM, Lai ST, Poon LL, et al. Coronavirus as a possible cause of severe acute respiratory syndrome. Lancet. 2003;361:1319-1325.
12. Drosten C, Günther S, Preiser W, et al. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N Engl J Med. 2003;348:1967-1976.
13. Ksiazek TG, Erdman D, Goldsmith CS, et al. A novel coronavirus associated with severe acute respiratory syndrome. N Engl J Med. 2003;348:1953-1966.
14. Marra MA, Jones SJM, Astell CR, et al. The genome sequence of the SARS-associated coronavirus. Science Mag [serial online]. 2003;300:1399-1404. Available at: www.sciencemag.org/cgi/content/abstract/1085953v1. Accessibility verified June 4, 2003.
15. Rota PA, Oberste MS, Monroe SS, et al. Characterization of a novel coronavirus associated with severe acute respiratory syndrome. Science Mag [serial online]. 2003;300:1394-1399. Available at: www.sciencemag.org/cgi/content/abstract/1085952v1. Accessibility verified June 4, 2003.
16. World Health Organization. First data on stability and resistance of SARS coronavirus compiled by members of WHO laboratory network. Available at: www.who.int/csr/sars/survival_2003_05_04/en/. Accessibility verified June 4, 2003.
17. Centers for Disease Control and Prevention. Severe acute respiratory syndrome - Singapore, 2003. MMWR Morb Mortal Wkly Rep. 2003;52:405-411.
18. Centers for Disease Control and Prevention. Guidelines for collection of specimens from potential cases of SARS. Available at: www.cdc.gov/ncidod/sars/specimen_collection_sars2.htm. Accessibility verified June 3, 2003.
19. Centers for Disease Control and Prevention. Interim laboratory biosafety guidelines for handling and processing specimens associated with severe acute respiratory syndrome (SARS). Available at: www.cdc.gov/ncidod/sars/sarslabguide.htm. Accessibility verified June 3, 2003.
20. So LK, Lau AC, Yam LY, et al. Development of a standard treatment protocol for severe acute respiratory syndrome. Lancet. 2003;361:1615-1617.